Differences between newborn and adult mice in their response to immune thrombocytopenia

Neonatology

Volumn 98, Issue 1, 2010, Pages 100-108

  Hu, Zhongbo ^a   Slayton, William B ^a   Rimsza, Lisa M ^b   Bailey, Matthew ^a,c   Sallmon, Hannes ^c,d   Sola Visner, Martha C ^a,c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Megakaryocyte; Thrombocytopenia

Indexed keywords

BIOLOGICAL MARKER; THROMBOCYTE ANTIBODY; VON WILLEBRAND FACTOR; ANTIBODY; VON WILLEBRAND ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL COUNT; CELL CULTURE; CELL SIZE; CELL VOLUME; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; HISTOLOGY; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOHISTOCHEMISTRY; LIVER; MEGAKARYOCYTE; MEGAKARYOPOIESIS; MOUSE; NEONATAL THROMBOCYTOPENIA; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SPLEEN; THROMBOCYTE COUNT; AGE; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; CYTOLOGY; DIAGNOSTIC USE; IMMUNOLOGY; PATHOLOGY; PREGNANCY; THROMBOCYTE; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES; BLOOD PLATELETS; BONE MARROW; CELL SIZE; FEMALE; LIVER; MICE; MICE, INBRED C57BL; PREGNANCY; SPLEEN; THROMBOCYTOPENIA; THROMBOPOIESIS; VON WILLEBRAND FACTOR;

MUS;

EID: 75649135006     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000280413     Document Type: Article

References (46)

1. Castle V, Andrew M, Kelton J, Giron D, Johnston M, Carter C: Frequency and mechanism of neonatal thrombocytopenia. J Pediatr 1986; 108: 749-755.
2. Mehta P, Vasa R, Neumann L, Karpatkin M: Thrombocytopenia in the high-risk infant. J Pediatr 1980; 97: 791-794.
3. Burstein SA, Harker LA: Control of platelet production. Clin Haematol 1983; 12: 3-22.
4. Hegyi E, Nakazawa M, Debili N, Navarro S, Katz A, Breton-Gorius J, Vainchenker W: Developmental changes in human megakaryocyte ploidy. Exp Hematol 1991; 19: 87-94.
5. Allen Graeve JL, de Alarcon PA: Megakaryocytopoiesis in the human fetus. Arch Dis Child 1989; 64: 481-484.
6. de Alarcon PA, Graeve JL: Analysis of megakaryocyte ploidy in fetal bone marrow biopsies using a new adaptation of the Feulgen technique to measure DNA content and estimate megakaryocyte ploidy from biopsy specimens. Pediatr Res 1996; 39: 166-170.
7. Mattia G, Vulcano F, Milazzo L, Barca A, Macioce G, Giampaolo A, Hassan HJ: Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release. Blood 2002; 99: 888-897.
8. Zauli G, Valvassori L, Capitani S: Presence and characteristics of circulating megakaryocyte progenitor cells in human fetal blood. Blood 1993; 81: 385-390.
9. Sola MC, Du Y, Hutson AD, Christensen RD: Dose-response relationship of megakaryocyte progenitors from the bone marrow of thrombocytopenic and non-thrombocytopenic neonates to recombinant thrombopoietin. Br J Haematol 2000; 110: 449-453.
10. Harker LA: Kinetics of thrombopoiesis. J Clin Invest 1968; 47: 458-465.
11. Harker LA: Thrombokinetics in idiopathic thrombocytopenic purpura. Br J Haematol 1970; 19: 95-104.
12. Sola-Visner MC, Christensen RD, Hutson AD, Rimsza LM: Megakaryocyte size and concentration in the bone marrow of thrombocytopenic and nonthrombocytopenic neonates. Pediatr Res 2007; 61: 479-484.
13. Oyaizu N, Yasumizu R, Miyama-Inaba M, Nomura S, Yoshida H, Miyawaki S, Shibata Y, Mitsuoka S, Yasunaga K, Morii S, et al: (NZW x BXSB)F1 mouse. A new animal model of idiopathic thrombocytopenic purpura. J Exp Med 1988; 167: 2017-2022.
14. Teeling JL, Jansen-Hendriks T, Kuijpers TW, De Haas M, van De Winkel JG, Hack CE, Bleeker WK: Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia. Blood 2001; 98: 1095-1099.
15. Crow AR, Song S, Semple JW, Freedman J, Lazarus AH: IVIg inhibits reticuloendothelial system function and ameliorates murine passive-immune thrombocytopenia independent of anti-idiotype reactivity. Br J Haematol 2001; 115: 679-686.
16. Sola MC, Rimsza LM: Mechanisms underlying thrombocytopenia in the neonatal intensive care unit. Acta Paediatr Suppl 2002; 91: 66-73.
17. Clapp DW, Baley JE, Gerson SL: Gestational age-dependent changes in circulating hematopoietic stem cells in newborn infants. J Lab Clin Med 1989; 113: 422-427.
18. Enzan H, Takahashi H, Kawakami M, Yamashita S, Ohkita T, Yamamoto M: Light and electron microscopic observations of hepatic hematopoiesis of human fetuses. II. Megakaryocytopoiesis. Acta Pathol Jpn 1980; 30: 937-954.
19. Forestier F, Daffos F, Catherine N, Renard M, Andreux JP: Developmental hematopoiesis in normal human fetal blood. Blood 1991; 77: 2360-2363.
20. Pahal GS, Jauniaux E, Kinnon C, Thrasher AJ, Rodeck CH: Normal development of human fetal hematopoiesis between eight and seventeen weeks' gestation. Am J Obstet Gynecol 2000; 183: 1029-1034.
21. Ebbe S, Stohlman Jr. F, Overcash J, Donovan J, Howard D: Megakaryocyte size in thrombocytopenic and normal rats. Blood 1968; 32: 383-392.
22. Odell TT, Murphy JR, Jackson CW: Stimulation of megakaryocytopoiesis by acute thrombocytopenia in rats. Blood 1976; 48: 765-775.
23. Shiotsu Y, Akinaga S, Yamashita K, Murakata C, Tamaoki T, Ishida Y, Kuriya S, Teramura M, Mizoguchi H: In vitro and in vivo effects of KT6352, a derivative of indolocarbazole compounds, on murine megakaryocytopoiesis. Exp Hematol 1998; 26: 1195-1201.
24. Hawley RG, Fong AZ, Burns BF, Hawley TS: Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus. J Exp Med 1992; 176: 1149-1163.
25. Ritchie KA, Aprikyan AA, Bowen-Pope DF, Norby-Slycord CJ, Conyers S, Bartelmez S, Sitnicka EH, Hickstein DD: The Tel-PDGFRbeta fusion gene produces a chronic myeloproliferative syndrome in transgenic mice. Leukemia 1999; 13: 1790-1803.
26. Levin J, Levin FC, Metcalf D: The effects of acute thrombocytopenia on megakaryocyte- CFC and granulocyte-macrophage- CFC in mice: studies of bone marrow and spleen. Blood 1980; 56: 274-283.
27. Li XM, Hu Z, Sola-Visner M, Hensel S, Garner R, Zafar AB, Wingard JR, Jorgensen ML, Fisher RC, Scott EW, Slayton WB: Sites and kinetics of donor thrombopoiesis following transplantation of whole bone marrow and progenitor subsets. Exp Hematol 2007; 35: 1567-1579.
28. Slayton WB, Georgelas A, Pierce LJ, Elenitoba- Johnson KS, Perry SS, Marx M, Spangrude GJ: The spleen is a major site of megakaryopoiesis following transplantation of murine hematopoietic stem cells. Blood 2002; 100: 3975-3982.
29. Slayton WB, Wainman DA, Li XM, Hu Z, Jotwani A, Cogle CR, Walker D, Fisher RC, Wingard JR, Scott EW, Sola MC: Developmental differences in megakaryocyte maturation are determined by the microenvironment. Stem Cells 2005; 23: 1400-1408.
30. Brown SL, Dale DC: Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells. Biol Blood Marrow Transplant 1997; 3: 341-343.
31. Becker PS, Wagle M, Matous S, Swanson RS, Pihan G, Lowry PA, Stewart FM, Heard SO: Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells. Biol Blood Marrow Transplant 1997; 3: 45-49.
32. Calhoun DA, Li Y, Braylan RC, Christensen RD: Assessment of the contribution of the spleen to granulocytopoiesis and erythropoiesis of the mid-gestation human fetus. Early Hum Dev 1996; 46: 217-227.
33. Pastos KM, Slayton WB, Rimsza LM, Young L, Sola-Visner MC: Differential effects of recombinant thrombopoietin and bone marrow stromal-conditioned media on neonatal versus adult megakaryocytes. Blood 2006; 108: 3360-3362.
34. Wickenhauser C, Thiele J, Lorenzen J, Schmitz B, Frimpong S, Schramm K, Neumann I, Zankovich R, Fischer R: Polycythemia vera megakaryocytes but not megakaryocytes from normal controls and patients with smokers polyglobuly spontaneously express IL-6 and IL-6R and secrete IL-6. Leukemia 1999; 13: 327-334.
35. Suen Y, Chang M, Lee SM, Buzby JS, Cairo MS: Regulation of interleukin-11 protein and mRNA expression in neonatal and adult fibroblasts and endothelial cells. Blood 1994; 84: 4125-4134.
36. Bobik R, Hong Y, Breier G, Martin JF, Erusalimsky JD: Thrombopoietin stimulates VEGF release from c-Mpl-expressing cell lines and haematopoietic progenitors. FEBS Lett 1998; 423: 10-14.
37. Ravid K, Beeler DL, Rabin MS, Ruley HE, Rosenberg RD: Selective targeting of gene products with the megakaryocyte platelet factor 4 promoter. Proc Natl Acad Sci USA 1991; 88: 1521-1525.
38. Avecilla ST, Hattori K, Heissig B, Tejada R, Liao F, Shido K, Jin DK, Dias S, Zhang F, Hartman TE, Hackett NR, Crystal RG, Witte L, Hicklin DJ, Bohlen P, Eaton D, Lyden D, De Sauvage F, Rafii S: Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med 2004; 10: 64-71.
39. Murray NA, Watts TL, Roberts IA: Endogenous thrombopoietin levels and effect of recombinant human thrombopoietin on megakaryocyte precursors in term and preterm babies. Pediatr Res 1998; 43: 148-151.
40. Sola MC, Calhoun DA, Hutson AD, Christensen RD: Plasma thrombopoietin concentrations in thrombocytopenic and nonthrombocytopenic patients in a neonatal intensive care unit. Br J Haematol 1999; 104: 90-92.
41. Corash L, Chen HY, Levin J, Baker G, Lu H, Mok Y: Regulation of thrombopoiesis: effects of the degree of thrombocytopenia on megakaryocyte ploidy and platelet volume. Blood 1987; 70: 177-185.
42. Abgrall JF, Berthou C, Sensebe L, Le Niger C, Escoffre M: Decreased in vitro megakaryocyte colony formation in chronic idiopathic thrombocytopenic purpura. Br J Haematol 1993; 85: 803-804.
43. Abgrall JF, el-Kassar N, Berthou C, Renard I, Cauvin JM, Le Pailleur A, Autrand C, Sensebe L, Guern G, Zilliken P, et al: In vitro megakaryocyte colony formation in patients with idiopathic thrombocytopenic purpura: differences between acute and chronic ITP. Int J Cell Cloning 1992; 10: 28-32.
44. De Alarcon PA, Mazur EM, Schmieder JA: In vitro megakaryocytopoiesis in children with acute idiopathic thrombocytopenic purpura. Am J Pediatr Hematol Oncol 1987; 9: 212-218.
45. Sugiyama H, Yagita M, Takahashi T, Nakamura K, Iho S, Hoshino T, Imura H: Megakaryocytopoiesis in idiopathic thrombocytopenic purpura. Nippon Ketsueki Gakkai Zasshi 1987; 50: 119-128.
46. Kühne T, Ryan G, Blanchette V, Semple JW, Hornstein A, Mody M, Chang W, McWhirter L, Freedman J: Platelet-surface glycoproteins in healthy and preeclamptic mothers and their newborn infants. Pediatr Res 1996; 40: 876-880.